<DOC>
	<DOCNO>NCT02233751</DOCNO>
	<brief_summary>Evaluation pharmacokinetic safety profile testosterone single dose use auto-injector</brief_summary>
	<brief_title>Pharmacokinetic Study Testosterone</brief_title>
	<detailed_description>Evaluation single-dose pharmacokinetics healthy male volunteer</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Healthy adult male subject , 1855 year age , inclusive , time signing informed consent ; Body weight â‰¥50 kg body mass index within range 1930 kg/m2 , inclusive , screen ; Medically healthy subject clinically insignificant screen checkin result ( medical history , 12lead electrocardiogram [ ECG ] , physical examination , laboratory test ) ; Subjects able understand willing able give sign informed consent trialrelated procedure perform . Currently diagnosed history asthma , urticarial , angioedema , anaphylaxis , atopic dermatitis , clinically significant abnormality skin abdomen , cancer , diabetes , clinically significant cardiovascular , respiratory , metabolic , renal , hepatic , gastrointestinal , hematological , dermatological , venereal , neurological , psychiatric , major disorder ; History benign prostate hypertrophy ( BPH ) , prostate cancer , abnormal prostate specific antigen ( PSA ) value ; PSA level &gt; 3 ng/ml screening ; Presence history gastrointestinal , hepatic renal disease , condition ( include surgery ) know interfere absorption , distribution , metabolism , excretion medicine ; Systolic blood pressure outside range 90 140 mmHg , diastolic blood pressure outside range 40 90 mmHg , and/or pulse rate outside range 40 100 beat per minute one repeat screen checkin ; Abnormal ECG screen judged Investigator ; History clinically significant drug and/or food allergy determine Investigator ; Allergy sesame , sesame oil , history hypersensitivity idiosyncratic reaction compound related study drug Subjects undergoing current treatment androgen ( i.e . dehydroepiandrosterone [ DHEA ] ) , anabolic steroid , sex hormone , drug interfere metabolism testosterone ( i.e . opioids , anastrozole , clomiphene , dutasteride , finasteride , flutamide , ketoconazole , spironolactone , testolactone ) ; Subjects treat within past 12 month estrogen , gonadotropin release hormone ( GnRH ) agonists , growth hormone ; Prescription , counter medication , vitamin , herbal dietary supplement take within 7 day 5 halflives ( whichever longer ) prior dose study medication duration study ; Positive screen human immunodeficiency virus ( HIV ) , hepatitis B , and/or hepatitis C screening ; Positive urine screen drug abuse ( amphetamine , barbiturate , benzodiazepine , cocaine , marijuana , methadone , methamphetamine , oxycodone , opiates ) positive breath alcohol test screening checkin</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Healthy Adult Males</keyword>
</DOC>